Sandoz receives FDA warning letter
Pharma Compliance Alert, September 3, 2008
An FDA inspection revealed significant deviations from Good Manufacturing Practice at Novartis’ Sandoz generic unit’s manufacturing facility, according to an agency warning letter.
- Establish and follow written procedures for production and process controls
- Thoroughly investigate any unexplained discrepancy or the failure of a batch or any of its components to meet any of its specifications
- Include in-process and laboratory control results in the batch record
- Include complete manufacturing and control instructions, sampling and testing procedures, specifications, and precautions to be followed
- Have laboratory controls to establish scientifically sound and appropriate specifications, standards, sampling plans, and test procedures
- Establish appropriate controls over computer or related systems
- Ensure that the responsibilities and procedures applicable to the quality control unit are followed
Most of the problems the FDA reported in the warning letter relate to Metoprolol, but the agency expressed concern that the violations could be indicative of problems and poor decisions made with other product validations.
Comments
0 comments on “Sandoz receives FDA warning letter ”
Related Products
-
ePharm5 InDepth
EPharm5 e-mail newsletter delivers the top 5 developments in pharma business innovation, with original research, interviews...
-
Complete Guide to Lab Safety, 3rd Ed.
The third edition of this popular resource makes training and compliance easier by consolidating regulations from all...
-
Big Pharma Performance Before, During and Beyond the Global Recession
This report assesses the performance of the leading 15 pharmaceutical companies up to, during and beyond the recent global...
Most Popular
- Articles
-
- HIPAA Q&A: Flu shot requirement for hospital employees
- Running an effective peer review committee meeting
- HealthDataInsights posts new issues for medical necessity claims
- Sneak Peek: Effort underway to establish caseload benchmarks
- New FAQ posted on storing laryngoscope blades
- Q/A: Coding for telescopic intraocular lens
- Tip: Perform your own internal investigation prior to government audit
- HIPAA 5010 deadline extended, but threat remains, says AMA
- HHS task force: Consider privacy, security with text messages
- What does case-mix index mean to you?
- E-mailed
-
- Running an effective peer review committee meeting
- HIPAA Q&A: Flu shot requirement for hospital employees
- What does case-mix index mean to you?
- HHS task force: Consider privacy, security with text messages
- Featured blog post: Nurses face felony charges after reporting physician to the Texas Medical Board
- Q/A: Coding for telescopic intraocular lens
- Q/A: Correct use of modifier -PT
- Tip: Correctly code bilateral pain management procedures
- "Wall fountains" may be spreading Legionnaires to patients, visitors
- 2012 CPT code changes for ASCs: Shoulder and knee scopes and pain management
- Searched